Ligand validation:3IK6

HCZ: 6-chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide

HCZ is a Ligand Of Interest in 3IK6 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3IK6_HCZ_B_800	1%	0%	0.434	0.651	10.75	7	17	16	6	0	100%	1
3IK6_HCZ_H_800	0%	0%	0.462	0.521	10.72	7.19	17	17	7	0	100%	1
3IK6_HCZ_B_262	0%	0%	0.482	0.522	10.86	6.75	17	15	6	0	100%	1
3IJX_HCZ_D_800	10%	1%	0.326	0.83	5.58	2.89	14	7	8	0	100%	1
8PC4_HCZ_B_608	2%	34%	0.421	0.726	1.36	1.23	3	3	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.